Re: A phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: Background and rationale of the radiotherapydadjuvant versus early salvage (RAVES) trial: Editorial comment

Samir S. Taneja

    Research output: Contribution to journalComment/debatepeer-review

    Fingerprint Dive into the research topics of 'Re: A phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: Background and rationale of the radiotherapydadjuvant versus early salvage (RAVES) trial: Editorial comment'. Together they form a unique fingerprint.